Skip to the page
pepts.wiki

We are not doctors and nothing here is medical advice. Always consult a medical professional first. Why we say this

Studied in peopleStub

VIP

Vasoactive intestinal peptide (aviptadil)

A 28 amino acid neuropeptide that relaxes smooth muscle and modulates immunity.

Reconstitution calculator

At a glance

Studied in people

There are published studies in people. It is not a licensed medicine in the United States or the European Union.

This page is a stub

The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.

How strong is the evidence

How far it has climbed

Every medicine climbs the same ladder. Most compounds never reach the top, and where one stands says how much its claims can carry.

  1. Licensed medicine

    A regulator has reviewed the trials and licensed it for a named use.

  2. Phase 3

    Large randomized trials, often thousands of people, against placebo or a standard treatment.

  3. Phase 2

    Mid-sized trials that measure dose against effect in people with the condition.

  4. Phase 1 and early human studies: VIP

    First studies in people: safety, and how the body handles it.

  5. Cells and animals

    Laboratory and animal work. An animal result is not a result in people.

4,403
papers on PubMed
1,470
of them in people
32
randomized trials
175
reviews

A count says how much has been published, not what it found. Counted on PubMed: 2026-11-16

Handling and reconstitution

From powder to a measured sample

The same four steps for any lyophilized vial. Laboratory handling, not use in a person.

  1. 1. Read the vial

    The label gives the mass of peptide in the vial, in milligrams. That number is the start of every calculation.

  2. 2. Add the diluent

    A measured volume of diluent goes in slowly, down the glass. Swirl gently; shaking can damage a peptide.

  3. 3. Work out the strength

    Concentration is mass divided by volume: 10 mg in 2 mL is 5 mg per mL.

  4. 4. Measure the sample

    Volume is the mass wanted divided by the concentration. On a U-100 syringe, 1 mL is 100 units.

The calculator below does the arithmetic and shows its working.

As powder

General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.

In solution

Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.

This is general practice for lyophilized peptides, not data on VIP itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage

Reconstitution calculator

Opens on vial sizes common for research peptides. Change any number. How the arithmetic works

Draw to

10 units

0.1 mL on a U-100 syringe

Concentration
2.5 mg/mL
Each unit holds
25 mcg
Samples in the vial
20
Sample
250 mcg

5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of VIP; no amount here is a recommendation.

VIP: on PubMed

What PubMed held for VIP on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.

4,403
papers
1,470
in humans
64
clinical trials
32
randomized trials
2012: 45 papers122013: 50 papers2014: 47 papers142015: 42 papers2016: 30 papers162017: 25 papers2018: 45 papers182019: 41 papers2020: 34 papers202021: 38 papers2022: 36 papers222023: 26 papers2024: 30 papers242025: 30 papers2026: 22 papers so far26
Papers per year, 2012 to 2026. The most in one year: 50.

Most relevant on PubMed

Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.

  1. Role of tear vasoactive intestinal peptide on dry eyes after laser keratorefractive surgery

    TrialKang Y, Hu Q, Li X, et al. BMC ophthalmology, 2023. PMID 37081425

  2. Vasoactive intestinal peptide as a bronchodilator in severe asthma

    TrialMorice AH, Sever PS Peptides, 1986. PMID 3529052

  3. Mechanisms of vasoactive intestinal peptide-mediated vasodilation in human skin

    Randomized trialWilkins BW, Chung LH, Tublitz NJ, et al. Journal of applied physiology (Bethesda, Md. : 1985), 2004. PMID 15155712

  4. Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis

    TrialPrasse A, Zissel G, Lützen N, et al. American journal of respiratory and critical care medicine, 2010. PMID 20442436

  5. Vasoactive intestinal Peptide as a diagnostic or prognostic biomarker in multiple sclerosis: A systematic review

    ReviewCabrera-Martín A, Juarranz Y, Gutiérrez-Cañas I, et al. Multiple sclerosis and related disorders, 2026. PMID 42447728

  6. Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical Trial

    Randomized trialPellesi L, Al-Karagholi MA, De Icco R, et al. JAMA network open, 2021. PMID 34357396

  7. Vasoactive intestinal peptide secreting tumour: An overview

    ReviewUna Cidon E World journal of gastrointestinal oncology, 2022. PMID 35582098

  8. Liposomal vasoactive intestinal peptide

    StudySethi V, Onyüksel H, Rubinstein I Methods in enzymology, 2005. PMID 15721392

Search used: ("vasoactive intestinal peptide"[ti] OR "vasoactive intestinal polypeptide"[ti]). Run it on PubMed

Research links

Also in Immune